×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Analyst Ratings and Price Targets (5/27/2022)

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
ABC
AmerisourceBergen
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ricky Goldwasser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$156.86
+0.7%
$178.00 ➝ $175.00Equal Weight
ACHL
Achilles Therapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.56
+3.2%
$17.00 ➝ $10.00
ADSK
Autodesk
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.38
+10.3%
$258.00 ➝ $245.00Equal Weight
ADSK
Autodesk
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.38
+10.3%
$298.00 ➝ $242.00Overweight
ADSK
Autodesk
Target Lowered byKeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.38
+10.3%
$260.00 ➝ $250.00Overweight
ADSK
Autodesk
Target Lowered byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.38
+10.3%
$230.00 ➝ $216.00Overweight
ADSK
Autodesk
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.38
+10.3%
$264.00 ➝ $258.00Buy
ADSK
Autodesk
Target Raised byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.38
+10.3%
$255.00 ➝ $260.00
ADSK
Autodesk
Reiterated byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matthew Broome
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.38
+10.3%
$250.00Buy
AEO
American Eagle Outfitters
Downgraded byJPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.09
-6.6%
$20.00 ➝ $15.00Overweight ➝ Neutral
AEO
American Eagle Outfitters
Target Lowered byTelsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.09
-6.6%
$25.00 ➝ $17.00Market Perform
AEO
American Eagle Outfitters
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.09
-6.6%
$30.00 ➝ $15.00
AEO
American Eagle Outfitters
Target Lowered byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.09
-6.6%
$23.00 ➝ $15.00
AEO
American Eagle Outfitters
Target Lowered byB. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.09
-6.6%
$22.00
AGI
Alamos Gold
Target Raised byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.58
+0.1%
C$17.50 ➝ C$18.25
ALLR
Allarity Therapeutics
Initiated byLADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.87
+39.3%
$8.00Buy
AMBA
Ambarella
Target Lowered byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Kelley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$88.10
+9.9%
$160.00 ➝ $136.00
AMED
Amedisys
Target Lowered bySVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$117.53
+0.1%
$131.00 ➝ $117.00Market Perform
AMH
American Homes 4 Rent
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$38.19
+2.6%
$41.00 ➝ $39.00Equal Weight
AMP
Ameriprise Financial
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Barnidge
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$278.49
+1.5%
$285.00 ➝ $275.00Underweight
AMZN
Amazon.com
Target Lowered byLoop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2,302.93
+3.7%
$3,750.00 ➝ $2,825.00Buy
AQN
Algonquin Power & Utilities
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$14.51
+0.1%
$16.00
ARGX
argenx
Target Raised byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Edward Tenthoff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$323.10
+2.3%
$375.00 ➝ $415.00Overweight
ARR
ARMOUR Residential REIT
Target Lowered byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.57
+0.7%
$8.00 ➝ $6.00
ASGN
ASGN
Target Lowered byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$95.62
+2.5%
$125.00 ➝ $101.00
ASPU
Aspen Group
Target Lowered byNorthland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.03
+4.0%
$4.50 ➝ $3.00Outperform
ATCO
Atlas
Downgraded byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.11
+1.0%
Outperform ➝ Neutral
AVDL
Avadel Pharmaceuticals
Target Lowered byCraig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.50
+133.6%
$20.00 ➝ $15.50
AVDL
Avadel Pharmaceuticals
Target Lowered byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.50
+133.6%
$17.00 ➝ $13.00Buy
AVDL
Avadel Pharmaceuticals
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.50
+133.6%
$13.00
AVDL
Avadel Pharmaceuticals
Target Lowered bySVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.50
+133.6%
$18.00 ➝ $6.00Outperform
AVGO
Broadcom
Target Raised byKeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$583.28
+5.9%
$720.00 ➝ $780.00Overweight
AVGO
Broadcom
Target Raised byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$583.28
+5.9%
$700.00 ➝ $725.00Buy
AVGO
Broadcom
Target Raised byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$583.28
+5.9%
$658.00
AXLA
Axcella Health
Target Lowered byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.96
+0.5%
$7.00
BABA
Alibaba Group
Target Lowered byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$93.41
-1.1%
$170.00 ➝ $161.00Overweight
BABA
Alibaba Group
Target Lowered byBenchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$93.41
-1.1%
$220.00 ➝ $200.00Buy
BABA
Alibaba Group
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Alicia Yap
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$93.41
-1.1%
$177.00 ➝ $176.00Buy
BE
Bloom Energy
Target Raised byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$18.28
+10.3%
$19.00
BHF
Brighthouse Financial
Target Raised byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$49.70
+2.6%
$47.00 ➝ $50.00Neutral
BIDU
Baidu
Target Lowered byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$139.09
+2.1%
$243.00 ➝ $235.00Overweight
BIDU
Baidu
Target Raised byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$139.09
+2.1%
$221.00 ➝ $223.00Buy
BIDU
Baidu
Target Lowered byBenchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$139.09
+2.1%
$330.00 ➝ $270.00Buy
BMEA
Biomea Fusion
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$5.81
+11.7%
$25.00 ➝ $16.00
BMO
Bank of Montreal
Target Lowered byDesjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Young
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$107.38
+1.5%
C$159.00 ➝ C$155.00Buy ➝ Buy
BNS
Bank of Nova Scotia
Target Lowered byDesjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.06
+1.5%
C$96.00 ➝ C$94.00
BOOT
Boot Barn
Upgraded byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$81.74
+4.5%
$115.00Neutral ➝ Outperform
BRZE
Braze
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$34.99
+8.5%
$72.00
BSX
Boston Scientific
Upgraded byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$41.20
+2.6%
$48.00Hold ➝ Buy
BUD
Anheuser-Busch InBev SA/NV
Target Lowered bySanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$56.65
+0.3%
$67.60
BURL
Burlington Stores
Target Raised byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$207.00
BURL
Burlington Stores
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$209.00
BURL
Burlington Stores
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$215.00
BURL
Burlington Stores
Target Lowered byLoop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$175.00 ➝ $135.00Sell
BURL
Burlington Stores
Target Lowered byTelsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$280.00 ➝ $250.00Outperform
BURL
Burlington Stores
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$223.00 ➝ $191.00
BURL
Burlington Stores
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$275.00 ➝ $205.00Outperform
BURL
Burlington Stores
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$171.63
+1.0%
$329.00 ➝ $315.00Overweight
BZUN
Baozun
Target Raised byHSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.27
-6.4%
$8.00 ➝ $9.00
C
Citigroup
Downgraded byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$53.62
-0.9%
$58.00Outperform ➝ Neutral
CATC
Cambridge Bancorp
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$84.10
-0.9%
$100.00
CGC
Canopy Growth
Reiterated byCfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Garrett Nelson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$4.88
-12.1%
$10.00Hold
CGC
Canopy Growth
Downgraded byBenchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$4.88
-12.1%
Hold ➝ Sell
CGC
Canopy Growth
Target Lowered byAlliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aaron Grey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$4.88
-12.1%
C$8.00 ➝ C$7.00
CI
Cigna
Target Raised byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$272.40
+1.3%
$235.00 ➝ $283.00Equal Weight
CI
Cigna
Target Raised bySanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$272.40
+1.3%
$258.00 ➝ $301.00Mkt Perform
CM
Canadian Imperial Bank of Commerce
Target Lowered byTD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mario Mendonca
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$54.43
+1.3%
C$82.00 ➝ C$78.00Buy ➝ Buy
CM
Canadian Imperial Bank of Commerce
Target Raised byNational Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$54.43
+1.3%
C$83.50 ➝ C$84.00
CM
Canadian Imperial Bank of Commerce
Target Lowered byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$54.43
+1.3%
C$85.00 ➝ C$83.00
CNO
CNO Financial Group
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$20.59
+0.3%
$23.00 ➝ $22.00Neutral
CODX
Co-Diagnostics
Reiterated byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Yi Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$5.50
+10.7%
$12.00Buy
COST
Costco Wholesale
Target Raised byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$470.76
+1.2%
$503.00 ➝ $543.00Buy
COST
Costco Wholesale
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$470.76
+1.2%
$600.00 ➝ $560.00Outperform
COST
Costco Wholesale
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Robert Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$470.76
+1.2%
$570.00 ➝ $550.00Neutral
COST
Costco Wholesale
Target Lowered byLoop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$470.76
+1.2%
$650.00 ➝ $610.00Buy
COST
Costco Wholesale
Target Lowered byTelsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$470.76
+1.2%
$615.00 ➝ $590.00Outperform
COST
Costco Wholesale
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$470.76
+1.2%
$590.00 ➝ $510.00Neutral
CRDF
Cardiff Oncology
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.30
+8.3%
$20.00 ➝ $7.00
CTMX
CytomX Therapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.62
+3.2%
$16.00 ➝ $10.00
DELL
Dell Technologies
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$49.58
+12.9%
$65.00 ➝ $60.00
DELL
Dell Technologies
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$49.58
+12.9%
$60.00 ➝ $56.00Equal Weight
DELL
Dell Technologies
Target Raised byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$49.58
+12.9%
$65.00 ➝ $67.00Buy
DG
Dollar General
Target Raised byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$228.38
+2.8%
$178.00 ➝ $227.00Hold
DLTR
Dollar Tree
Target Raised byGuggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$165.00
+1.4%
$185.00
DLTR
Dollar Tree
Target Raised byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$165.00
+1.4%
$178.00
DLTR
Dollar Tree
Target Raised byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kelly Bania
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$165.00
+1.4%
$180.00 ➝ $187.00
DLTR
Dollar Tree
Target Raised byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$165.00
+1.4%
$150.00 ➝ $160.00Equal Weight
DLTR
Dollar Tree
Target Raised byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$165.00
+1.4%
$140.00 ➝ $150.00Equal Weight
DLTR
Dollar Tree
Target Raised byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Peter Keith
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$165.00
+1.4%
$181.00 ➝ $191.00
DOMO
Domo
Target Lowered byJMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$34.29
+13.8%
$88.00 ➝ $59.00
DSGX
The Descartes Systems Group
Target Lowered byRoyal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.56
+0.8%
$100.00 ➝ $85.00Outperform
ELY
Callaway Golf
Reiterated byBerenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rudy Yang
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$21.99
+5.0%
$34.00Buy
ENLC
EnLink Midstream
Target Raised byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.38
+3.7%
$12.00 ➝ $13.00Neutral
ENS
EnerSys
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$70.77
+1.6%
$88.00 ➝ $80.00Outperform
EXK
Endeavour Silver
Target Lowered byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.72
+1.1%
C$7.50 ➝ C$6.50
FDX
FedEx
Target Set byBerenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
William Fitzalan ...
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$219.67
+3.5%
$330.00
FISV
Fiserv
Target Raised byTigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$101.37
+2.1%
$150.00 ➝ $152.00
FMTX
Forma Therapeutics
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$5.77
+4.3%
$46.00
FMTX
Forma Therapeutics
Target Lowered bySVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$5.77
+4.3%
$25.00 ➝ $23.00Outperform
FTCH
Farfetch
Target Lowered byBTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.73
+26.7%
$26.00 ➝ $16.00Buy
FTCH
Farfetch
Target Lowered byWells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.73
+26.7%
$35.00 ➝ $25.00Overweight
FTCH
Farfetch
Target Lowered byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.73
+26.7%
$16.00 ➝ $8.00Neutral
FTCH
Farfetch
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.73
+26.7%
$56.00 ➝ $30.00Overweight
GEF
Greif
Downgraded byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$59.49
-3.8%
$71.00 ➝ $52.00Outperform ➝ Market Perform
GPK
Graphic Packaging
Upgraded byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Wilde
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$22.45
+4.7%
$20.00 ➝ $25.00Market Perform ➝ Outperform
GPS
Gap
Downgraded byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kimberly Greenberger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$13.00 ➝ $8.00Equal Weight ➝ Underweight
GPS
Gap
Downgraded byJPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matthew Boss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$11.00 ➝ $9.00Neutral ➝ Underweight
GPS
Gap
Target Lowered byTelsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$15.00 ➝ $13.00Market Perform
GPS
Gap
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$13.00 ➝ $10.00Neutral
GPS
Gap
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$17.00 ➝ $12.00
GPS
Gap
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$8.00 ➝ $7.00
GPS
Gap
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$14.00 ➝ $11.00Neutral
GPS
Gap
Target Lowered byWells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$20.00 ➝ $16.00Overweight
GPS
Gap
Target Lowered byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$14.00 ➝ $11.00Neutral
GPS
Gap
Target Lowered byGuggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Robert Drbul
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.60
+4.3%
$18.00
GRCL
Gracell Biotechnologies
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.15
+5.0%
$25.00 ➝ $10.00
GRTX
Galera Therapeutics
Downgraded byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.62
-6.9%
Neutral ➝ Underperform
GTLB
GitLab
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$42.94
+7.2%
$60.00
HARP
Harpoon Therapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.08
+5.6%
$14.00 ➝ $9.00
HIBB
Hibbett
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$52.50
+2.7%
$75.00 ➝ $70.00
HOTH
Hoth Therapeutics
Target Lowered byBenchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$0.44
+2.5%
$4.00
IBRX
ImmunityBio
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.92
+14.6%
$20.00 ➝ $10.00
IMAB
I-Mab
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$8.27
-26.9%
$80.00 ➝ $35.00
INVH
Invitation Homes
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$38.54
+3.2%
$44.50 ➝ $42.50Overweight
IOT
Samsara
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.50
+4.5%
$20.00
IOVA
Iovance Biotherapeutics
Target Lowered byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.02
-53.6%
$20.00
IOVA
Iovance Biotherapeutics
Target Lowered byChardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.02
-53.6%
$44.00 ➝ $31.00Buy
IOVA
Iovance Biotherapeutics
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.02
-53.6%
$31.00 ➝ $27.00Outperform
IOVA
Iovance Biotherapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.02
-53.6%
$20.00 ➝ $13.00Neutral
IQ
iQIYI
Upgraded byBenchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.98
+1.8%
$7.00Hold ➝ Buy
JACK
Jack in the Box
Target Lowered byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.04
-2.7%
$110.00 ➝ $90.00Outperform
JACK
Jack in the Box
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.04
-2.7%
$98.00 ➝ $89.00Equal Weight
JACK
Jack in the Box
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.04
-2.7%
$92.00 ➝ $77.00Neutral
JACK
Jack in the Box
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.04
-2.7%
$108.00 ➝ $86.00
JACK
Jack in the Box
Target Lowered byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.04
-2.7%
$130.00 ➝ $107.00Buy
JACK
Jack in the Box
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.04
-2.7%
$99.00 ➝ $84.00Underperform
JOAN
JOANN
Target Lowered byTelsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$8.31
+3.9%
$11.00 ➝ $9.00Market Perform
KIRK
Kirkland's
Target Lowered byCraig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$6.78
+2.3%
$9.00
LNC
Lincoln National
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$58.32
+2.0%
$75.00 ➝ $70.00Overweight
LPTX
Leap Therapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.11
-7.5%
$6.00 ➝ $4.00
M
Macy's
Target Lowered byTelsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$23.40
+2.1%
$30.00 ➝ $28.00Market Perform
M
Macy's
Upgraded byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$23.40
+2.1%
$20.00 ➝ $22.00Underweight ➝ Equal Weight
M
Macy's
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$23.40
+2.1%
$25.00 ➝ $23.00Neutral
M
Macy's
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$23.40
+2.1%
$34.00 ➝ $29.00
M
Macy's
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$23.40
+2.1%
$30.00
MAXN
Maxeon Solar Technologies
Target Lowered byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.90
+7.1%
$23.00 ➝ $18.00
MDT
Medtronic
Target Lowered byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$99.08
-0.4%
$111.00
MDT
Medtronic
Target Lowered byRoyal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$99.08
-0.4%
$135.00 ➝ $122.00
MDT
Medtronic
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$99.08
-0.4%
$120.00 ➝ $117.00Buy
MDT
Medtronic
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$99.08
-0.4%
$149.00 ➝ $121.00
MDT
Medtronic
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Cecilia Furlong
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$99.08
-0.4%
$120.00 ➝ $115.00Equal Weight
MDT
Medtronic
Downgraded byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$99.08
-0.4%
Buy ➝ Hold
MDWT
Midwest
Target Raised byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Barnidge
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.24
+9.3%
$10.00 ➝ $12.00Neutral
ME
23andMe
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
2.86
-1.0%
$6.00 ➝ $3.00Neutral
ME
23andMe
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
2.86
-1.0%
$11.00 ➝ $7.00Outperform
MRKR
Marker Therapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$0.30$3.50 ➝ $1.50
MRTX
Mirati Therapeutics
Target Lowered bySVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Berens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$39.81
-31.9%
$164.00 ➝ $111.00Outperform
MRVL
Marvell Technology
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Karl Ackerman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$100.00 ➝ $85.00
MRVL
Marvell Technology
Target Lowered byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$100.00 ➝ $90.00Buy
MRVL
Marvell Technology
Target Lowered byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$98.00 ➝ $82.00
MRVL
Marvell Technology
Target Lowered byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Quinn Bolton
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$105.00 ➝ $75.00
MRVL
Marvell Technology
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$100.00 ➝ $85.00Outperform
MRVL
Marvell Technology
Target Lowered byCraig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$90.00
MRVL
Marvell Technology
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$80.00 ➝ $68.00Equal Weight
MRVL
Marvell Technology
Target Lowered byKeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$95.00 ➝ $90.00Overweight
MRVL
Marvell Technology
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$60.82
+6.7%
$80.00 ➝ $75.00
MTEM
Molecular Templates
Downgraded byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.03
+6.0%
$1.50Buy ➝ Underperform
NLTX
Neoleukin Therapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.00
-2.0%
$25.00 ➝ $6.00
NRDY
Nerdy
Target Lowered byCanaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.59
+8.4%
$8.00 ➝ $7.00
NRIX
Nurix Therapeutics
Target Lowered byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gil Blum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.02
+14.5%
$48.00 ➝ $38.00Buy
NTAP
NetApp
Downgraded byOTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$73.05
+3.6%
Positive
NTAP
NetApp
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$73.05
+3.6%
$85.00
NVDA
NVIDIA
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Tristan Gerra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$188.11
+5.4%
$225.00 ➝ $165.00Neutral
OCUL
Ocular Therapeutix
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.19
+6.0%
$16.00 ➝ $10.00
OI
O-I Glass
Upgraded byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$16.98
+8.4%
$15.00 ➝ $19.00Neutral ➝ Buy
OPGN
OpGen
Reiterated byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Yi Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$0.56
+16.6%
$3.00Buy
OR
Osisko Gold Royalties
Target Lowered byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$11.64
+0.7%
C$23.00 ➝ C$22.00
OYST
Oyster Point Pharma
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$4.07
+5.4%
$60.00 ➝ $15.00
PATH
UiPath
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$17.74
-1.3%
$43.00 ➝ $27.00
PD
PagerDuty
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$25.79
+6.8%
$40.00
PFE
Pfizer
Target Set byBerenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Luisa Hector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$53.91
-0.1%
$50.00
PRU
Prudential Financial
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$106.27
+1.6%
$118.00 ➝ $110.00Neutral
PSTG
Pure Storage
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$24.38
+5.7%
$30.00
RAIN
Rain Therapeutics
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.50
+7.8%
$26.00 ➝ $12.00
RBLX
Roblox
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$31.81
+4.0%
$32.00 ➝ $27.00Equal Weight
RDBX
Redbox Entertainment
Downgraded byB. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Wold
Subscribe to MarketBeat All Access for the recommendation accuracy rating
7.71
+2.1%
Neutral ➝ Sell
RETA
Reata Pharmaceuticals
Target Raised byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$29.63
+6.6%
$43.00 ➝ $46.00Buy
RGA
Reinsurance Group of America
Target Raised byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$126.25
+2.3%
$135.00 ➝ $150.00Overweight
RGTI
Rigetti Computing
Initiated byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
8.81
+5.6%
Outperform
RGTI
Rigetti Computing
Initiated byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
8.81
+5.6%
Outperform
RH
RH
Target Lowered byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$291.03
+4.5%
$315.00
ROKU
Roku
Upgraded byPivotal Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$96.47
+9.0%
$80.00Sell ➝ Hold
RY
Royal Bank of Canada
Target Raised byNational Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gabriel Dechaine
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$103.04
+2.3%
C$147.00 ➝ C$148.00
RY
Royal Bank of Canada
Target Lowered byTD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$103.04
+2.3%
C$150.00 ➝ C$145.00
RY
Royal Bank of Canada
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$103.04
+2.3%
C$153.00 ➝ C$152.00
RY
Royal Bank of Canada
Target Lowered byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$103.04
+2.3%
C$142.00 ➝ C$140.00
SBNY
Signature Bank
Target Lowered byStephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$211.49
+3.9%
$325.00
SIVB
SVB Financial Group
Target Lowered byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$492.02
+4.0%
$700.00 ➝ $620.00
SPLK
Splunk
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$108.50
+6.4%
$145.00 ➝ $120.00Neutral
SRZN
Surrozen
Downgraded byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.77
+8.6%
Buy ➝ Neutral
SU
Suncor Energy
Target Raised byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$40.61
+2.6%
C$50.00 ➝ C$58.00
SUMO
Sumo Logic
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$8.49
+10.1%
$13.00
SUMO
Sumo Logic
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rob Owens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$8.49
+10.1%
$12.50 ➝ $10.00
SWTX
SpringWorks Therapeutics
Target Lowered byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$18.36
-40.4%
$110.00 ➝ $50.00Outperform
TCN
Tricon Residential
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.29
+1.7%
$15.75 ➝ $13.50Equal Weight
TD
Toronto-Dominion Bank
Target Raised byNational Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Dechaine
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$75.61
+1.3%
C$100.00 ➝ C$102.00
TD
Toronto-Dominion Bank
Target Raised byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$75.61
+1.3%
C$102.00 ➝ C$103.00
TD
Toronto-Dominion Bank
Target Raised byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$75.61
+1.3%
C$95.00 ➝ C$97.00
TITN
Titan Machinery
Target Lowered byStephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$27.44
+2.3%
$44.00 ➝ $41.00Overweight
TRUP
Trupanion
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$68.96
+6.9%
$95.00 ➝ $80.00Overweight
TTWO
Take-Two Interactive Software
Target Lowered byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$125.78
+2.0%
$171.00
ULTA
Ulta Beauty
Target Raised byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$425.08
+12.5%
$470.00 ➝ $485.00Outperform
ULTA
Ulta Beauty
Target Raised byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Erinn Murphy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$425.08
+12.5%
$465.00 ➝ $485.00Overweight
ULTA
Ulta Beauty
Upgraded byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$425.08
+12.5%
$400.00 ➝ $475.00Hold ➝ Buy
ULTA
Ulta Beauty
Target Raised byJPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Christopher Horvers
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$425.08
+12.5%
$460.00 ➝ $480.00
ULTA
Ulta Beauty
Target Raised byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Binetti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$425.08
+12.5%
$455.00 ➝ $475.00Outperform
ULTA
Ulta Beauty
Target Raised byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$425.08
+12.5%
$450.00 ➝ $490.00Outperform
UPS
United Parcel Service
Target Set byBerenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
William Fitzalan ...
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$182.53
+2.3%
$200.00
URBN
Urban Outfitters
Downgraded byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$21.68
+4.0%
$34.00 ➝ $25.00Overweight ➝ Equal Weight
VIVO
Meridian Bioscience
Reiterated byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Yi Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$27.88
+5.9%
$30.00Buy
VMW
VMware
Target Raised byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$129.26
+3.9%
$138.00
VSAT
Viasat
Target Lowered byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$41.77
+14.3%
$58.00 ➝ $51.00
WBX
Wallbox
Initiated byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$10.58
+4.0%
Neutral
WDAY
Workday
Target Lowered byDA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$250.00 ➝ $220.00
WDAY
Workday
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$290.00 ➝ $235.00Outperform
WDAY
Workday
Target Lowered byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$185.00 ➝ $170.00Neutral
WDAY
Workday
Target Lowered byWells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$300.00 ➝ $240.00Overweight
WDAY
Workday
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$300.00 ➝ $200.00Buy
WDAY
Workday
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$300.00 ➝ $230.00Neutral
WDAY
Workday
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$340.00 ➝ $225.00
WDAY
Workday
Target Lowered byWells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$300.00 ➝ $240.00Overweight
WDAY
Workday
Target Lowered byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$185.00 ➝ $170.00Neutral
WDAY
Workday
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$290.00 ➝ $235.00Outperform
WDAY
Workday
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$320.00 ➝ $310.00
WDAY
Workday
Target Lowered byJPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$280.00 ➝ $235.00
WDAY
Workday
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$360.00 ➝ $230.00Overweight
WDAY
Workday
Target Lowered byKeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$229.00 ➝ $207.00Overweight
WDAY
Workday
Target Lowered byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$238.00 ➝ $208.00Overweight
WDAY
Workday
Target Lowered byMonness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$200.00
WDAY
Workday
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$190.00
WDAY
Workday
Target Lowered byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$249.00 ➝ $239.00
WDAY
Workday
Target Lowered byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$275.00 ➝ $220.00
WDAY
Workday
Target Lowered byDA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$250.00 ➝ $220.00Buy
WDAY
Workday
Target Lowered byCanaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$325.00 ➝ $200.00Buy ➝ Buy
WDAY
Workday
Target Lowered byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$158.79
-5.6%
$300.00 ➝ $200.00Buy
WSM
Williams-Sonoma
Target Lowered byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$130.91
+0.7%
$186.00 ➝ $173.00Overweight
ZBH
Zimmer Biomet
Downgraded byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$119.83
-0.7%
Buy ➝ Hold
ZS
Zscaler
Reiterated byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gregg Moskowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$210.00Buy
ZS
Zscaler
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$405.00 ➝ $194.00Buy
ZS
Zscaler
Target Lowered byCanaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Michael
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$320.00 ➝ $210.00
ZS
Zscaler
Target Lowered byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$200.00
ZS
Zscaler
Target Lowered byCowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$405.00 ➝ $194.00Outperform
ZS
Zscaler
Target Lowered byBTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gray Powell
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$326.00 ➝ $184.00Buy
ZS
Zscaler
Target Lowered byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rob Owens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$260.00 ➝ $160.00
ZS
Zscaler
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$295.00 ➝ $225.00
ZS
Zscaler
Target Lowered byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$270.00 ➝ $172.00
ZS
Zscaler
Target Lowered byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$300.00 ➝ $200.00Outperform
ZS
Zscaler
Target Lowered byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$325.00 ➝ $200.00Buy
ZS
Zscaler
Target Lowered byDeutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$280.00 ➝ $190.00
ZS
Zscaler
Target Lowered byCredit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$410.00 ➝ $310.00Outperform
ZS
Zscaler
Target Raised byBarclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.00
+12.6%
$147.00 ➝ $168.00Equal Weight
ZYME
Zymeworks
Target Raised bySVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Berens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$6.87
+7.8%
$18.00 ➝ $19.00Outperform

Always Get the Latest Analyst Ratings and Price Targets: Stay ahead of the market with MarketBeat.com's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register.

This page was last refreshed on Saturday at 04:14 PM ET.

Terms like “Buy”, “Sell”, and “Hold” are synonymous with financial analysts’ reports, yet very few people have a clear understanding of what they are and the best way to use them for value generation in the stock market.  The terms are usually the result of thorough investigations carried out by brokerage firms and analysts as they look to make it easy for investors to make informed decisions about investments.

Market ratings are a multi-level recommendation system based on facts and the opinion of a financial analyst. The fact that there is a multitude of firms issuing differing ratings and a lack of a standard terminology explains why it is essential to understand what the ratings are all about and their meaning before using them for investment decisions.

What Are Stock Ratings

A stock rating refers to an evaluation of a stock’s expected performance in a given time period.  The rating is usually accompanied by a target price that analysts or brokerage firm issue with the aim of helping clients understand what is the fair price of a stock compared to its market value.

A stock rating will often come with a price target that shows what analysts believe is the fair value for the stock. Whenever the price target exceeds the market value, then it implies analysts believe the stock is a buy.  If the market price for the stock exceeds the target price, analysts or brokerage firms would say that the stock is a sell.

Understanding Analysts Stock Ratings

Analysts' ratings range from a simple buy, sell or hold to an equal-weight, overweight or outperform. Many brokerage firms rate a stock on a scale of one to five stars, with five being the highest rating. The ratings are assigned depending on the kind of earnings the company has reported or what it is expected to report as well as on valuations and stock price.

Corporate governance, as well as the scalability of a company’s business, are also taken into consideration when rating stocks. Analysts also pay close attention to a company’s competitive edge in the industry, as it is known to affect performance most of the time.

Market conditions also play into how stocks are rated. For example, in a bull market, analysts are usually swayed to keep favorable ratings for a long time while upgrading share price target. Conversely, during a bear market, analysts may resort to downgrading stock ratings.

While ratings may seem straightforward to an investing newcomer, in reality, a rating from one brokerage firm may mean an entirely different thing in another firm. For example, an outperform rating issued by one firm may mean a buy for another firm, while a sell may mean under­perform.

When it comes to integrating analysts' ratings, it is important first to review a firm’s rating scale to get a full understanding of what it is all about and what it means.  For example, a stock with the potential of delivering a 15% upside in price may be rated as a buy while one with a 5% upside rated as a hold.

Types of Stock Ratings

Buy Stock Rating: A buy rating indicates that a stock is worth buying at a given market price as it is destined to rise. Some firms use ‘strong buy’ to indicate how confident they are that a stock will climb higher given the strong fundamentals backing a move on the upside.

Sell Stock Rating: Sell recommendations are normally issued whenever analysts believe a stock is overvalued or fundamentals do not add up to support any movements on the upside. Some firms use ‘strong sell' to indicate that it is time to liquidate the security.

Hold Stock Rating: A security hit with a hold rating is most of the time expected to perform at the same pace as other stocks in the sector.

Underperform:  Analysts issue an underperform rating whenever they feel a stock is likely to fair worse than the overall market.  The rating is most of the time expressed as a moderate sell, warning investors who are long that a stock is losing upside momentum.

Outperform Stock Rating:  An outperform rating indicates that a stock is likely to perform much better than the market when it comes to returns. Also known as moderate buy or overweight, the rating hints at an uptrend gaining momentum.

It is important to read each rating definition to have a clear understanding of what it means given that ratings from different firms do differ a great deal.  Some ratings do offer specific recommendations while others are usually general in nature. One firm may say it expects a stock to appreciate by between 10 and 20% while another firm may say it expects a stock to appreciate over the next 12 months.

Brokerage Firm

Buy

Strong Buy

Out­perform

Hold

Sell

Under­perform

BB&T Capital Markets

 

Esti­mated return of greater than or equal to 25%

 

Esti­mated Total Return  greater than or equal to 0%

 

Esti­mated Total Return of Less than 0%

Blay­lock Partners

Stock Expected to out­perform market indexes by 20%

 

 

Expects stock to track recog­nized market indexes

Expects stock  to under­perform the overall market by 20%

 

Barring­ton Research

 

Expected to out­perform the market over the next 6 months

Expected to out­perform the market over the next 12 months

 

Expected to significantly under­perform the market as a result of deterior­ating fundamentals

 

Brean Murray & Co

Stock expected to out­perform the market over the next 12 months with moderate risks to funda­mentals

Stock expected to out­perform the market over the next 12 months it minimal risks to funda­mentals

 

Expected to perform in line with the market over the next 6-12 months

Exacted to under­perform the market over the next 6-12 months with high risk to funda­mentals

 

Deutsche Bank  Securities

Stock poised to outperform the market by 10% or more over the next 12 months

Repre­sents firm best picks with a high degree of confi­dence. Stock expected to out­perform the market

 

 

 

Stock expected to under­perform the market by 10% over the next 12 months

Jefferies & Co

A stock is expected to appre­ciate by 20% or more. The total return should exceed the industry average

 

 

Stock expected to change plus or minus 10%. The total return should be  in line with the industry's average

Stock expected to decrease by more than 10%

 

 

Why Stock Ratings Matter

While investors have a love-hate relationship with stock analysts’ ratings, they still matter a lot, as they convey how professionals feel about a given security. They will always stand out in part because they are the result of reasoned and objective analysis of experienced professionals.

Analysts and brokerage firms spend a good amount of time and effort to analyze companies in a bid to come up with accurate stock ratings that investors can rely on for making informed investment decisions. Investors should always remember that analysts do their best with stock ratings to find good investments for their clients in order to secure their reputation in the industry as well as the commissions they earn for such pieces of information.

Legitimate ratings will always be valuable pieces of information that investors can rely on to beat the market and in the process generate substantial returns. However, while it is essential to always be on the lookout for analysts’ ratings, it does not mean that investors should always adjust their position based on such reports.

Such reports should only be used to complement individual research work prior to making an investment decision.  Stock analysts’ reports should thus be used to find a company with a durable competitive advantage.

Stock ratings are a great place to start when selecting stocks

Stock analysts' rating pages are a great place to start when looking for potential stocks to invest in. Such recommendations go a long way in providing insight on stocks that are performing and likely to perform even better going forward.

Reputable analysts and brokerage firms issue recommendations upon carrying out extensive research of a company’s operations and performance. The analysis also takes into consideration some of the market conditions that are likely to affect a company in the long run.

By going through such research pages, one can get an insight on where to start when carrying out due diligence on the stocks to invest in. In addition, such reports may provide common investment strategies that one can deploy on a given stock to be able to generate some returns.

Before making an investment decision, it is essential to consider analysts' ratings in addition to other metrics. Analyst’s ratings are never 100% accurate, which means they cannot be taken at face value.  That said, it is important to analyze everything from P/E ratio to earnings per share as well as dividends, risk, and growth of financial strength.

The key to success is analyzing below the surface when it comes to stock analysts' ratings. Never assume that just because a stock is rated a buy, it means it can be bought at any time at any price.

Bottom Line

Analysts’ recommendations in the form of stock ratings are the foundation of equity research reports that should always be used in combination with other personal research work for investment decisions. Buy, sell and hold recommendations should never be put to use without first understanding a firm’s entire scale of ratings.

It is also important for investors to note that analysts and brokerage firms also have agendas. While an analyst's obligation should be to retail shareholders, in reality, that is not always the case.

Some analysts are employed by institutions that own stakes in companies they have already initiated coverage on. Large financial firms, as well as hedge funds and securities, do benefit from certain analyst ratings. When such sums are at stake, it is common for these analysts to issue ratings that are favorable to their holdings, which may not be an accurate reflection of the market conditions.

However, that does not mean that an analyst’s ratings are useless. Analyst's stock research reports do contain vital information. Such information when complemented with other information found by carrying out due diligence could go a long way in helping one make a profitable investment decision.  Stock ratings should always be used as a source of data that complements one's research rather than completes it.

 



Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.